This paper is in the following e-collection/theme issue:

Non-Randomized Study Protocols and Methods (Non-eHealth) (683) Immunology, Allergy, Rheumatology (140) Safety and Error Prevention in Health (240) Pharmacology and Pharmaceutics (111) Adverse Drug Events Detection, Pharmacovigilance and Surveillance (215) Pharmacovigilance (171)

Published on in Vol 14 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/70312, first published .
Therapeutic Drug Monitoring for Precision Dosing of Janus Kinase Inhibitors: Protocol for a Prospective Observational Study

Therapeutic Drug Monitoring for Precision Dosing of Janus Kinase Inhibitors: Protocol for a Prospective Observational Study

Therapeutic Drug Monitoring for Precision Dosing of Janus Kinase Inhibitors: Protocol for a Prospective Observational Study

Authors of this article:

Jérémie Tachet1 Author Orcid Image ;   Laurent A Decosterd2 Author Orcid Image ;   Monia Guidi1, 3, 4 Author Orcid Image ;   François R Girardin1, 2 Author Orcid Image
Article Authors Cited by (1) Tweetations Metrics

Journals

  1. Tachet J, Marzolini C, Decosterd L, Guidi M, Girardin F. Therapeutic drug monitoring of Janus kinase inhibitors for precision dosing: where do we stand ?. Expert Review of Clinical Pharmacology 2025;18(10):753 View